| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3946610 | Gynecologic Oncology | 2006 | 10 Pages | 
Abstract
												These findings demonstrate that PEITC exhibits cytotoxicity towards OVCAR-3 cells and induces apoptosis via caspase-9 and -3 pathways. PEITC inhibits Akt, ERK1/2 survival signaling, and c-Myc while simultaneously activating pro-apoptotic p38 and JNK1/2. Systematic preclinical and clinical trials with PEITC in ovarian cancer are indicated.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												K.S. Satyan, Narasimha Swamy, Don S. Dizon, Rakesh Singh, Cornelius O. Granai, Laurent Brard, 
											